Trends in meningococcal disease: challenges for vaccine control when disease is rare

Andrew J. Pollard*, Hannah Christensen

*Corresponding author for this work

Research output: Contribution to journalEditorial (Academic Journal)

1 Citation (Scopus)

Abstract

In most wealthy and in many middle income countries, capsular group B Neisseria meningitidis (MenB) remains an important cause of invasive disease, particularly in the era of control of other major bacterial pathogens, such as MenC, Haemophilus influenzae type b, and vaccine-type pneumococcus. Two new MenB vaccines (now licensed in many countries) provide the potential for a comprehensive approach to controlling these invasive bacterial pathogens. However, decisions about vaccination at the population level are complex when there are low rates of disease: cost-effectiveness is a particularly important factor.
Original languageEnglish
Pages (from-to)380-381
Number of pages2
JournalMedical Journal of Australia
Volume207
Issue number9
Early online date6 Nov 2017
DOIs
Publication statusPublished - 2017

Fingerprint Dive into the research topics of 'Trends in meningococcal disease: challenges for vaccine control when disease is rare'. Together they form a unique fingerprint.

  • Cite this